))
Talking the Cure: Discussing COVID-19’s impact on FDA’s inspection program and next steps after the pandemic
Manage episode 290829676 series 2916794
Contenido proporcionado por Hogan Lovells. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Hogan Lovells o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In this episode, Phil Katz and Jim Johnson continue their conversation about the impact of COVID-19 on FDA’s drug inspection program and the steps companies should take now and in preparation for when the pandemic is coming to an end. For all updates around COVID-19, visit our COVID-19 hub. You can find additional thought leadership and information regarding Medical Devices and Technology Regulatory on HL Engage. If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.
…
continue reading
52 episodios
Compartir
